Surface Pharmaceuticals

Last updated: April 15, 2024

Kamran Hosseini, President & CEO

Country: USA | Funding: $46.8M (+)

Website: http://surfacepharma.com/

Surface Pharmaceuticals intends to advance state of the art treatments for ocular surface diseases.